WHO ICTRP trial

Can exercise mechanically suppress tumour formation and growth in advanced…

ACTRN12616000179437 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12616000179437
Public title Can exercise mechanically suppress tumour formation and growth in advanced prostate cancer patients with sclerotic bone metastases? Safety, feasibility and efficacy of a modular, multi-modal exercise program with spinal isometric training (M3EP-SIT).
Scientific title Can exercise mechanically suppress tumour formation and growth in advanced prostate cancer patients with sclerotic bone metastases? Safety, feasibility and efficacy of the M3EP-SIT program.
Primary sponsor Edith Cowan University
Secondary sponsors Dr Nicolas Hart
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Prostate Cancer;Bone Metastases; Prostate Cancer Bone Metastases;Cancer - Prostate;Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Interventions This is a single-blinded (investigators blinded to group allocation), two-armed, randomised and controlled (exercise versus usual care) explorative phase 1 clinical trial which will examine the safety, feasibility and efficacy of combining…
Registration date Nov 2, 2016
Target size 40
Registry page anzctr.org.au

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations